Home › Gestational Diabetes › NCT07174245
Pregnancy and Postpartum CGM in GDM
Pregnancy and Postpartum Continuous Glucose Monitoring in Gestational Diabetes
Who can join
Ages 18 and older · Women
Full eligibility criteria
Inclusion Criteria: * Diagnosis of gestational diabetes during current pregnancy * age 18 or older * prescribed Dexcom G7 Exclusion Criteria: * Pregestational diabetes * known skin adhesive allergy which inhibits ongoing use of CGM * chronic oral steroid use.
About the study
Gestational diabetes (GDM) is one of the most common complications of pregnancy, and up to one third of women with GDM will have abnormal blood sugars after their pregnancy. To screen for abnormal blood sugars, standard of care is a 4-12 week postpartum oral glucose tolerance test (OGTT). However only 17-60% of women actually have this test performed. This study is to assess continuous glucose monitor data from the third trimester and up to 14 days postpartum to find predictors of postpartum OGTT results.
What is being tested
- continuous glucose monitor (device)
Sponsor: Icahn School of Medicine at Mount Sinai · Participants: 40 · Started: Aug 5, 2025
Contact the study team
- Sarah Rancic · Phone: 212-241-5355
- Grenye O'Malley · Phone: 212-241-7173
Official record on ClinicalTrials.gov — NCT07174245
Locations in the U.S.
| New York | Icahn School of Medicine at Mount Sinai, New York |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.